Skip to main content
Log in

Activation mechanisms to chemical toxicity

  • Review
  • Metabolism of Xenobiotics
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The pathobiology of chemical toxicity may involve “acute lethal injury” (necrosis), “autoxidative injury” (oxygen toxicity), “immunological injury” (neoantigen formation), and malignancy. Toxic chemicals may be activated by reduction, conjugation, radical formation, or oxidation. Oxidative activation may be effected by cytochromes P-450/P-448, flavoprotein monooxygenases, or hydroxyl radicals. The alternative pathways of oxidative metabolism of toxic chemicals, namely, detoxication and activation, are catalysed by the phenobarbital-induced cytochromes P-450 and by the 3-methylcholanthrene-induced cytochromes P-448 respectively. Oxidative metabolism by cytochromes P-450 is followed by conjugation and detoxication, whereas oxidative metabolism by cytochromes P-448 yields reactive intermediates which are not readily conjugated, and thus react with vital intracellular macromolecules, resulting in necrosis, redox cycling and oxygen radical formation, neoantigen production, and mutations. The molecular dimensions of specific substrates, inhibitors and inducers of the PB-cytochromes P-450 indicate that they are globular and are different from those of the cytochromes P-448 which are planar, suggesting that the active sites of the two families of enzymes are different. Oxidative metabolism of planar substrates of cytochromes P-448 results in conformationally-hindered oxygenations, which inhibits subsequent conjugations. Cytochrome P-448 activity may be quantified by the oxidative deethylation of 7-ethoxyresorufin which, unlike benzo(a)pyrene hydroxylation (AHH) is a specific reaction for this family of enzymes. Oxidative metabolism of chemicals varies inversely with the body weight of the animal species, so that chemical toxicity involving oxidative activation, redox cycling, and reactive oxygen is greater the smaller the animal species.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ahe Dvd, Janich S, Scheidereit C, Renkawitz R, Schütz G, Beato M (1985) Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters. Nature 313: 706–709

    Google Scholar 

  • Albert A (198) Selective Toxicity: The physico-chemical basis of therapy. 7th Edition. Chapman and Hall. London and New York

  • Aström A, DePierre J (1985) Metabolism of 2-acetylaminofluorene by eight different forms of cytochrome P-450 isolated from rat liver. Carcinogenesis 6: 113–120

    Google Scholar 

  • Bakke J, Gustafsson JA (1984) Mercapturic acid pathway metabolites of xenobiotics: Generation of potentially toxic metabolites during enterohepatic circulation. TIPS 5: 517–521

    Google Scholar 

  • Breacker PJ (1983) Species differences in mixed-function oxidations. PhD Thesis, University of Surrey

  • Burke MD, Prough RA, Mayer RI (1978) Characteristics of a microsomal P-448-mediated reaction ethoxyresorufin O-deethylation. Drug Metab Dispos 5: 1–8

    Google Scholar 

  • Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT (1985) Ethoxy-, pentoxy- and benzyloxy-phenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34: 3337–3345

    Google Scholar 

  • Calabrese EJ (1984) Suitability of animal models for predictive toxicology: Theoretical and parctical considerations. Drug Metab Rev 15: 505–523

    Google Scholar 

  • Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res 42: 4875–4917

    Google Scholar 

  • Delaforge M, Ioannides C, Parke DV (1980) Inhibition of cytochrome P-448 mixed-function oxidase activity following administration of 9-hydroxyellipticine to rats. Chem Biol Inter 32: 101–110

    Google Scholar 

  • Frank L, Massaro D (1980) Oxygen toxicity. Am J Med 69: 117–126

    Google Scholar 

  • Gelboin HV (1983) Carcinogens, drugs and cytochromes P-450. New Engl J Med 309: 105–106

    Google Scholar 

  • Glatt H, Friedberg T, Grover PL, Sims P, Oesch F (1983) Inactivation of a diol-epoxide and a K region epoxide with high efficiency by glutathione transferase X. Cancer Res 43: 5713–5717

    Google Scholar 

  • Gonzalez FJ, Kimura S, Nebert DW (1985) Comparison of the flanking regions and introns of the mouse 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P 1-450 and P 3-450 genes. J Biol Chem 260: 5040–5049

    Google Scholar 

  • Guengerich FP, Dannan GA, Wright ST, Martin MV (1982) Purification and characterisation of microsomal cytochrome P-450s. Xenobiotica 12: 701–716

    Google Scholar 

  • Haniu M, Ryan DE, Iida S, Lieber CS, Levin W, Shively JE (1984) NH2-terminal sequence analyses of four rat hepatic microsomal cytochromes P-450. Arch Biochem Biophys 235: 304–311

    Google Scholar 

  • Hara E, Kawajiri K, Gotoh O, Tagashira Y (1981) Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of 2-acetylaminofluorene by rat liver microsomes. Cancer Res 41: 253–257

    Google Scholar 

  • Hinson JA (1983) Reactive metabolites of phenacetin and acetaminophen: A review. Environ Health Perspect 49: 71–79

    Google Scholar 

  • Ioannides C, Lum PY, Parke DV (1984) Cytochrome P-448 and the activation of toxic chemicals and carcinogens. Xenobiotica 14: 119–138

    Google Scholar 

  • Igarashi S, Yonekawa H, Kawajiri K, Watanabe J, Kimura T, Kodama M, Nagata C, Tagashira Y (1982) Participation of the microsomal electron transport system in mutagenic activation of 4-diemthylaminoazobenzene, 4-methylaminoazobenzene and their 3′-methyl derivatives. Biochem Biophys Res Commun 106: 164–169

    Google Scholar 

  • Ishii K, Ando M, Kamataki T, Kato R, Nagao M (1980) Metabolic activation of mutagenic tryptophan pyrolysis products (Trp-P-I and Trp-P-2) by a purified cytochrome P-450-dependent monooxygenase system. Cancer Lett 9: 271–276

    Google Scholar 

  • Ishii K, Yamazoe Y, Kamataki T, Kato R (1981) Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido [1, 2-a: 3′, 2′-d] imidazole and 2-amino-dipyrido [1, 2-a: 3′, 2′-d] imidazole by purified cytochrome P-450. Chem Biol Interact 38: 1–13

    Google Scholar 

  • Jerina DM, Lehr RE (1977) The bay region theory: A quantum mechanical approach to aromatic hydrocarbon induced carcinogenesis. In: Ullrich W, Roots I, Hildebrandt AG, Estabrook RW, Conney AH (eds) Microsomes and drug oxidations (Proc. of the Third International Symposium). Pergamon Oxford, pp 709–720

    Google Scholar 

  • Johnson EF, Levitt DS, Muller-Eberhard V, Thorgeirsson SS (1980) Catalysis of divergent pathways of 2-acetylaminofluorene metabolism by multiple forms of cytochrome P-450. Cancer Res 40: 445–449

    Google Scholar 

  • Jordan VC (1984) Biochemical pharmacology of anti-estrogen action. Pharmacol Rev 36: 245–275

    Google Scholar 

  • Kadlubar FF, Frederick CB, Weis CC, Zenser TV (1982) Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. Biochem Biophys Res Commun 108: 253–258

    Google Scholar 

  • Kärenlampi SO, Eisen HJ, Hankinson O, Nebert DW (1983) Effects of cytochrome P1-450 inducers on the cell surface receptors for epidermal growth factor, phorbol 12, 13-dibutyrate, or insulin of cultures mouse hepatoma cells. J Biol Chem 258: 10378–10383

    Google Scholar 

  • Lesca P, Lecointe P, Paoletti C, Mansuy D (1979) Ellipticines as potent inhibitors of microsomes-dependent chemical mutagenesis. Chem Biol Interact 25: 279–287

    Google Scholar 

  • Levin W, Wood AW, Lu AYH, Ryan D, West S, Conney AH, Thakker DR, Yagi H, Jerina DM (1977) Role of purified cytochrome P-448 and epoxide hydrase in the activation and detoxification of benzo(a)pyrene. In: Jerina DM (ed) American Chemical Society ACS Symposium Series No 44. Drug Metabolism Concepts, pp 99–125

  • Lewis DFV, Ioannides C, Parke DV (1986) Molecular dimensions of the substrate binding site of cytochrome P-448. Biochem Pharmacol 35: 2179–2185

    Google Scholar 

  • Lu AYH, Kuntzman R, West S, Jacobson M, Conney AH (1972) Reconstitued liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. II Role of the cytochrome P-450 and P-448 fractions in drug and steroid hydroxylations. J Biol Chem 247: 1727–1734

    Google Scholar 

  • Masson HA, Ioannides C, Gorrod JW, Gibson GG (1983) The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test. Carcinogenesis 4: 1583–1586

    Google Scholar 

  • Miwa GT, Walsh JS, Lu AYH (1984) Kinetic isotope effects on cytochrome P-450-catalyzed oxidation reactions: The oxidative O-dealkylation of 7-ethoxycoumarin. J Biol Chem 259: 3000–3004

    Google Scholar 

  • Nordqvist M, Thakker DR, Levin W, Yagi H, Ryan DE, Thomas PE, Conney AH, Jerina DM (1979) The highly tumorigenic 3, 4-dihydrodiol is a principal metabolite formed from dibenzo(a, h)anthracene by liver enzymes. Mol Pharmacol 16: 643–655

    Google Scholar 

  • Norman RL, Muller-Eberhard U, Johnson EF (1979) The role of cytochrome P-450 forms in 2-aminoanthracene and benzo(a)pyrene mutagenesis. Biochem Biophys Res Commun 89: 195–201

    Google Scholar 

  • Oesch F, Guenther TM (1983) Effects of the modulation of epoxide hydrolase activity on the binding of benzo(a)pyrene metabolites to DNA in the intact nuclei. Carcinogenesis 4: 57–65

    Google Scholar 

  • Parke DV (1982) Mechanisms of chemical toxicity: A unifying hypothesis. Reg Toxicol Pharmacol 2: 267–286

    Google Scholar 

  • Parke DV (1983) Survey of drug-metabolising enzymes. Biochem Soc Trans II: 457–458

    Google Scholar 

  • Parke DV (1984) Development of detoxication mechanisms in the neonate. In: Kacew S, Reasor MJ (ed) Toxicology and the newborn. Elsevier, Amsterdam, pp 1–31

    Google Scholar 

  • Parke DV (1985) The role of cytochrome P-450 in the metabolism of pollutants. Marine Environ Res 17: 97–100

    Google Scholar 

  • Parke DV, Ioannides C (1981) The role of nutrition in toxicology. Ann Rev Nutr I: 207–234

    Google Scholar 

  • Parke DV, Ioannides C (1984) Reactive intermediates and oxygen toxicity in liver injury. In: Keppler D, Popper H, Bianchi L, Reuter W (ed) Falk Symposium 38, Mechanisms of Hepatocyte Injury and Death. MTP Press Lancaster, pp 37–48

    Google Scholar 

  • Parke AL, Parke DV (1987) Genetic and environmental aspects of drug metabolism relevant to side-effects in arthritic drug metabolism relevant to side-effects in arthritic disease. In: Rainsford K (ed) Proceedings of the Second Symposium on the Adverse Effects of Non-Steroidal Anti-Inflammatory Drugs. CRC Press Inc. (in press)

  • Pelkonen O, Sotaniemi EA, Ahokas JT (1985) Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. Br J Clin Pharmacol 19: 59–66

    Google Scholar 

  • Phillipson CE, Godden PMM, Ioannides C, Parke DV (1982) The mutagenicity of 9-hydroxyellipticine and its induction of cytochrome P-448 activity in rat liver microsomes. Carcinogenesis 3: 1179–1182

    Google Scholar 

  • Phillipson CE, Godden PMM, Lum PY, Ioannides C, Parke DV (1984) Determination of cytochrome P-448 activity in biological tissues. Biochem J 221: 81–88

    Google Scholar 

  • Ryan DE, Thomas PE, Levin W (1982) Purification and characterization of a minor form of hepatic microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls. Arch Biochem Biophys 216: 272–288

    Google Scholar 

  • Sartorelli AC (1986) The role of mitomycin antibiotics in the chemotherapy of solid tumours. Biochem Pharmacol 35: 67–69

    Google Scholar 

  • Sogawa K, Gotoh O, Kawajiri K, Fujii-Kuriyama Y (1984) Distinct organisation of methylcholanthrene-and phenobarbital-inducible cytochrome P-450 genes in the rat. Proc Natl Acad Sci USA 81: 5066–5070

    Google Scholar 

  • Sogawa K, Gotoh O, Kawajiri K, Harada T, Fujii-Kuriyama Y (1985) Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450 (P-450 d) gene in the rat. J Biol Chem 260: 5026–5032

    Google Scholar 

  • Statham CN, Boyd MR (1982) Effects of phenobarbital and 3-methylcholanthrene on the in vivo distribution, metabolism and covalent binding of 4-ipomeanol in the rat; implications for target organ toxicity. Biochem Pharmacol 31: 3973–3977

    Google Scholar 

  • Steele CM, Masson HA, Battershill JM, Gibson GG, Ioannides C (1983) Metabolic activation of paracetamol by highly purified forms of cytochrome P-450. Res Commun Chem Pathol Pharmacol 40: 109–119

    Google Scholar 

  • Thomas PE, Reidy J, Reik LM, Ryan DE, Koop DR, Levin W (1984) Use of monoclonal antibody probes against rat hepatic cytochromes P-450c and P-450d to detect immunochemically related isozymes in liver microsomes from different species. Arch Biochem Biophys 235: 239–253

    Google Scholar 

  • Walker CH (1980) Species variations in some hepatic microsomal enzymes that metabolic xenobiotics. In: Bridges JW, Chasseaud LF (ed) Progress in Drug Metabolism. Vol 5. Wiley, Chichester, pp 113–164

    Google Scholar 

  • Wang CY, Zukowski K, Lee M-S (1985) Glucuronidation of carcinogenic arylamine metabolites by rat liver microsomes. Biochem Pharmacol 34: 837–841

    Google Scholar 

  • Watabe T, Fujieda T, Hiratsuka A, Ishizuka T, Hakamata Y, Ogura K (1985) The carcinogen, 7-hydroxymethyl-12-methylbenz(a)anthracene, is activated and covalently binds to DNA via a sulphate ester. Biochem Pharmacol 34: 3002–3005

    Google Scholar 

  • Wolff T, Greim H, Huang MT, Miwa GT, Lu AYH (1980) Aldrin epoxidation catalyzed by purified rat liver cytochromes P-450 and P-448: High selectivity for cytochrome P-450. Eur J Biochem III:545–551

    Google Scholar 

  • Yoshizawa H, Uchimaru R, Kamataki T, Kato R, Ueno Y (1982) Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver. Cancer Res 42: 1120–1124

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dedicated to Professor Dr. Herbert Remmer on the occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parke, D.V. Activation mechanisms to chemical toxicity. Arch Toxicol 60, 5–15 (1987). https://doi.org/10.1007/BF00296939

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296939

Key words

Navigation